譚國欣 女 理學博士 副教授 碩士生導師

  2022年2月通過高層次人才引進到365英国上市官网在线工作。

  郵箱：tanguoxintgx@163.com

     1.教育背景

  2015.08-2021.09 沈陽藥科大學 藥劑學 博士（碩博連讀）

  2010.09-2014.07 内蒙古醫科大學 藥學 學士

  2.科研情況

  主要緻力于非病毒基因載體在眼部疾病中的應用和納米制劑的研究，在Acta Biomaterialia、International Journal of Pharmaceutics等SCI期刊上發表研究性論文7篇，其中第一作者5篇。參與過國家自然科學基金面上項目、青年科學基金項目等。

     3.研究領域

  核酸藥物遞送和納米藥物遞送

  4.社會兼職

  Acta Biomaterialia和Journal of Drug Delivery Science and Technology雜志審稿人

5.代表性項目

 [1].國家自然科學基金委員會，面上項目，81773670，基于AS1411與NLS的視網膜級聯靶向非病毒基因載體構建及其抗CNV機制研究，2018-01-01至2021-12-31，48萬元，在研，參與

[2].國家自然科學基金委員會，青年科學基金項目，81703455，基于多巴胺過表達調節的分子印迹-固相生物催化型給藥系統的構建及評價，2018-01-01至2020-12-31，20.1萬元，結題，參與

6.代表性成果

[1]. Guoxin Tan, Dandan Liu, Renfang Zhu, Hao Pan, Jiayang Li, Weisan Pan. A core-shell nanoplatform as a nonviral vector for targeted delivery of genes to the retina [J]. Acta Biomater, 2021,134: 605-620.

[2]. Guoxin Tan, Jinyu Li, Yiming Song, Yibin Yu, Dandan Liu, Weisan Pan. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome[J]. Acta Biomater, 2019,99: 350-362.

[3]. Guoxin Tan, Jiayang Li, Dandan Liu, Hao Pan, Renfang Zhu, Yue Yang, Weisan Pan. Amino acids functionalized dendrimers with nucleus accumulation for efficient gene delivery[J]. Int J Pharm, 2021,602: 120641.

[4]. Guoxin Tan, Shihui Yu, Jinyu Li, Weisan Pan. Development and characterization of nanostructured lipid carriers based chitosan thermosensitive hydrogel for delivery of dexamethasone[J]. Int J Biol Macromol, 2017,103: 941-947.

[5]. Guoxin Tan, Shihui Yu, Jinyu Li, Weisan Pan. Development and characterization of nanostructured lipid carriers based chitosan thermosensitive hydrogel for delivery of dexamethasone[J]. Int J Biol Macromol, 2017,103: 941-947.

[6]. Jinyu Li, Guoxin Tan, Bingchao Cheng, Dandan Liu, Weisan Pan. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular[J]. Eur J Pharm Biopharm, 2017,120: 89-97.

[7]. Shihui Yu, Guoxin Tan, Dandan Liu, Xinggang Yang, Weisan Pan. Nanostructured lipid carrier (NLC)-based novel hydrogels as potential carriers for nepafenac applied after cataract surgery for the treatment of inflammation: design, characterization and in vitro cellular inhibition and uptake studies[J]. RSC Advances, 2017,7(27): 16668-16677.